Management of Psoriatic Nail Disease

Seminars in Cutaneous Medicine and Surgery

Volumn 28, Issue 1, 2009, Pages 39-43

  de Berker, David ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALEFACEPT; BETAMETHASONE DIPROPIONATE; CALCIPOTRIOL; CLOBETASOL PROPIONATE; COSMETIC; CYCLOSPORIN; DITHRANOL; EFALIZUMAB; ETANERCEPT; ETRETIN; FLUOROURACIL; FUMARIC ACID DERIVATIVE; INFLIXIMAB; METHOTREXATE; PSORALEN; RETINOID; RETINOID DERIVATIVE; SALICYLIC ACID; STEROID; TAZAROTENE; TRIAMCINOLONE ACETONIDE; VITAMIN D DERIVATIVE;

BIOLOGICAL THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE EXACERBATION; DISEASE SEVERITY; ELECTRON THERAPY; HUMAN; HYPERKERATOSIS; NAIL DISEASE; NAIL FOLD IRRITATION; ONYCHOLYSIS; PSORIASIS; PUSTULAR PSORIASIS; PUSTULE; PUVA; QUALITY OF LIFE; REVIEW; SKIN IRRITATION; TREATMENT PLANNING; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

HUMANS; IMMUNOLOGIC FACTORS; INJECTIONS; NAIL DISEASES; PSORIASIS; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEROIDS;

EID: 63049083901     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2008.12.003     Document Type: Review

References (54)

1. Samman P. The Nails in Disease. (edn 3) (1978), Heinemann, London
2. de Jong E.M.G.J., Seegers B.A.M.P.A., Gulinck M.K., et al. Psoriasis of the nails associated with disability in a large number of patients: Results of a recent interview with 1728 patients. Dermatology 193 (1996) 300-303
3. Gupta A.K., Lynde C.W., Jain H.C., et al. A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: A multicentre study. Br J Dermatol 136 (1997) 786-789
4. Rich P., and Scher R.K. Nail psoriasis severity index: A useful tool for evaluation of nail psoriasis. J Am Acad Derm 49 (2003) 206-212
5. Cassell S.E., Bieber J.D., Rich P., et al. The modified nail psoriasis severity index: Validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J Rheumatol 34 (2007) 123-129
6. André J. Artificial nails and psoriasis. J Cosmet Dermatol 4 (2005) 103-106
7. Jiaravuthisan M.M., Sasseville D., Vender R.B., et al. Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 57 (2007) 1-27
8. Wolf R., Tur E., and Brenner S. Corticosteroid-induced "disappearing digit. " Arch Dermatol 23 (1990) 755-756
9. Requena L., Zamora E., Martin L., et al. Acroatrophy secondary to long-standing applications of topical steroids. Arch Dermatol 126 (1990) 1013-1014
10. Scher R.K., Stiller M., and Zhu Y.I. Tazarotene 0.1% gel in the treatment of fingernail psoriasis: A double-blind, randomized, vehicle-controlled study. Cutis 68 (2001) 355-358
11. Tosti A., Piraccini B.M., Cameli N., et al. Calcipotriol in nail psoriasis: A controlled double blind comparison with betamethasone dipropionate and salicylic acid. Br J Dermatol 139 (1998) 655-659
12. Frederiksson T. Topically applied fluorouracil in the treatment of psoriatic nails. Arch Dermatol 110 (1974) 735
13. Fritz K. Psoriasis of the nail. Successful topical treatment with 5-fluorouracil. Z Hautkr 64 (1988) 1083-1088
14. Tsuji T., and Nishimura M. Topically administered fluorouracil in acrodermatitis continua of Hallopeau. Arch Derm 127 (1991) 27-28
15. Tosti A., Guerra L., Bardazzi F., et al. Topical cyclosporin in nail psoriasis. Dermatologica 180 (1990) 110 (letter)
16. Prins A.M., Vos K., and Franssen E.J. Instability of topical cyclosporin emulsion for nail psoriasis. Dermatology 215 (2007) 362-363
17. Sánchez Regaña M., Martín Ezquerra G., Umbert Millet P., et al. Treatment of nail psoriasis with 8% clobetasol nail lacquer: Positive experience in 10 patients. J Eur Acad Dermatol Venereol 19 (2005) 573-577
18. Yamamoto T., Katayama I., and Nishioka K. Topical anthralin therapy for refractory nail psoriasis. J Derm 25 (1998) 231-233
19. Peachey R.D.G., Pye R.J., and Harman R.R. The treatment of psoriatic nail dystrophy with intradermal steroid injections. Br J Dermatol 95 (1976) 75-78
20. Abell E., and Samman P.D. Intradermal triamcinolone treatment of nail dystrophies. Br J Dermatol 89 (1973) 191-197
21. Gerstein W. Psoriasis and lichen planus of the nails. Arch Dermatol 86 (1962) 419-421
22. Bleeker J.J. Intradermal triamcinolone acetonide treatment of psoriatic nail dystrophy with port-o-jet. Br J Dermatol 92 (1975) 479
23. de Berker D., and Lawrence C.M. A simplified protocol of nail steroid injection for psoriatic nail dystrophy. Br J Dermatol 138 (1998) 90-95
24. Saleem K., and Azim W. Treatment of nail psoriasis with a modified regimen of steroid injections. J Coll Phys Surg Pak 18 (2008) 78-81
25. Gottlieb N.L., and Riskin W.G. Complications of local corticosteroid injection. JAMA 43 (1989) 1547-1548
26. Taras J.S., Iams G.J., Gibbons M., et al. Flexor pollicis longus rupture in a thumb: A case report. J Hand Surg 20A (1995) 276-277
27. Fitzgerald B.T., Hofmeister E.P., Fan R.A., et al. Delayed flexor digitorum superficialis and profundus ruptures in a trigger finger after a steroid injection: A case report. J Hand Surg [Am] 30 (2005) 479-482
28. Björkman A., and Jörgsholm P. Rupture of the extensor pollicis longus tendon: A study of aetiological factors. Scand J Plast Reconstr Surg Hand Surg 38 (2004) 32-35
29. Jakubík J. Finger tendon rupture following local application of triamcinolone acetonide (Kenalog A-40). Acta Chir Plast 23 (1981) 180-188
30. Dobson R., and Thiers B. Year Book Dermatology (1981), Year Book Medical Publishers Inc, Chicago 288
31. Caccialanza M., Frigerio U., and Della R. Fotochemioterapia orale Nel trattamento della psoriasi ungueale. G Its Dermatol Vener 117 (1982) 251-254
32. Marks J.L., and Scher R.K. Response of psoriatic nails to oral photochemotherapy. Arch Dermatol 116 (1980) 1023-1024
33. Handfield-Jones S.E., Boyle J., and Harman R.R.M. Local PUVA: Treatment for nail psoriasis. Br J Dermatol 116 (1987) 280
34. Yu R.C.H., and King C.M. A double blind study of superficial radiotherapy in psoriatic nail dystrophy. Acta Derm venereol 72 (1992) 134-136
35. Kwang T.Y., Nee T.S., and Seng K.T.H. A therapeutic study of nail psoriasis using electron beams. Acta Derm-venereol (Stockh) 75 (1994) 90
36. Lindelöf B. Psoriasis of the nails treated with Grenz rays: A double-blind bilateral trial. Acta Dermatol Venereol 69 (1988) 80-82
37. Rados J., Dobrić I., Pasić A., et al. Normalization in the appearance of severely damaged psoriatic nails using soft X-rays. A case report. Acta Dermatovenerol Croat 15 (2007) 27-32
38. Mahrle G., Schulze H.J., Färber L., et al. Low-dose short-term cyclosporin versus etretinate in psoriasis: Improvement of skin, nail, and joint involvement. J Am Acad Dermatol 32 (1995) 78-88
39. Tosti A., Ricotti C., Romanelli P., et al. Evaluation of the efficacy of acitretin therapy for nail psoriasis. Arch Dermatol 145 (2009) 269-271
40. Arnold W.P., Gerritsen M.J., and van de Kerkhof P.C. Response of nail psoriasis to cyclosporin. Br J Dermatol 129 (1993) 750-751
41. Baran R. Retinoids and the nails. J Dermatol Treat 1 (1990) 151-154
42. Vlachou C., and Berth-Jones J. Nail psoriasis improvement in a patient treated with fumaric acid esters. J Dermatolog Treat 18 (2007) 175-177
43. Lawry M. Biological therapy and nail psoriasis. Dermatol Ther 20 (2007) 60-67
44. Sfikakis P.P., Iliopoulos A., Elezoglou A., et al. Psoriasis induced by antitumour necrosis factor therapy: A paradoxical adverse reaction. Arthritis Rheum 52 (2005) 2513-2518
45. Reich K., Nestle F.O., Papp K., et al. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: A Phase III, multicentre, double-blind trial. Lancet 366 (2005) 1367-1374
46. Rich P., Griffiths C.E., Reich K., et al. Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. J Am Acad Dermatol. 2008 58 (2008) 224-231
47. Bianchi L., Bergamin A., de Felice C., et al. Remission and time of resolution of nail psoriasis during infliximab therapy. J Am Acad Dermatol. 2005 52 (2005) 736-737
48. Rigopoulos D., Gregoriou S., Stratigos A., et al. Evaluation of the efficacy and safety of infliximab on psoriatic nails: An unblinded, nonrandomized, open-label study. Br J Derm 159 (2008) 453-456
49. Körver J.E., Langewouters A.M., Van De Kerkhof P.C., et al. Therapeutic effects of a 12-week course of alefacept on nail psoriasis. J Eur Acad Dermatol Venereol 20 (2006) 1252-1255
50. Lamerson C., Stevens G., and Sax K. Treatment of nail psoriasis with efalizumab: A preliminary study. Cutis 82 (2008) 217-220
51. Rallis E., Stavropoulou E., Rigopoulos D., et al. Rapid response of nail psoriasis to etanercept. J Rheumatol 35 (2008) 544-545
52. Weisshaar E., and Diepgen T.L. Successful etanercept therapy in therapy refractory acrodermatitis continua suppurativa Hallopeau. J Dtsch Dermatol Ges 5 (2007) 489-492
53. Piraccini B.M., Tosti A., Iorizzo M., et al. Pustular psoriasis of the nails: Treatment and long-term follow-up of 46 patients. Br J Dermatol 144 (2001) 1000-1005
54. Sotiriadis D., Patsatsi A., Sotiriou E., et al. Acrodermatitis continua of Hallopeau on toes successfully treated with a two-compound product containing calcipotriol and betamethasone dipropionate. J Dermatolog Treat 18 (2007) 315-318